Bibliographie (2530)
Large populational study finds prior SARS-CoV-2 infection reduces the risk of breakthrough infection following mRNA vaccination.
dimanche, 14 novembre 2021 22:26 Écrit par Zouhair SouissiAssociation of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar – JAMA Commentaries: Vaccine plus previous infection may offer enhanced COVID-19 protection – CIDRAP Prior SARS-CoV-2 infection and risk of breakthrough infection following mRNA vaccination – News Medical Commentary on Twitter Study found prior #SARSCoV2 infection was associated with […]
The post Large populational study finds prior SARS-CoV-2 infection reduces the risk of breakthrough infection following mRNA vaccination. appeared first on Links Medicus.
Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.
vendredi, 12 novembre 2021 11:51 Écrit par Zouhair SouissiGlobal surveillance, research, and collaboration needed to improve understanding and management of long COVID – The Lancet Related: Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection. Update to post-acute sequelae of SARS-CoV-2 infection: Caring […]
The post Global surveillance, research, and collaboration needed to improve understanding and management of long COVID. appeared first on Links Medicus.
2022 ASA Guidelines for Management of the Difficult Airway.
vendredi, 12 novembre 2021 11:51 Écrit par Zouhair Souissi2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway – Anesthesiology Related: Consensus-based recommendations for management of the difficult airway: part 1. Difficult airway management encountered in an unconscious patient. Difficult airway management in neonates and infants: knowledge of devices and a device-oriented strategy. Consensus Guideline: Pediatric Airway Management in COVID-19 […]
The post 2022 ASA Guidelines for Management of the Difficult Airway. appeared first on Links Medicus.
ERS Guidelines: High-flow nasal cannula in acute respiratory failure.
vendredi, 12 novembre 2021 11:51 Écrit par Zouhair SouissiERS Clinical Practice Guidelines: High-flow nasal cannula in acute respiratory failure – European Respiratory Journal
The post ERS Guidelines: High-flow nasal cannula in acute respiratory failure. appeared first on Links Medicus.
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method.
vendredi, 12 novembre 2021 11:51 Écrit par Zouhair SouissiInfection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method – The Lancet Infectious Diseases Commentary from the author on Twitter (thread – click for more) Honoured to lead this Delphi on Infection Control in ICU for SARS-CoV-2 with global experts https://t.co/39NTHgfyZR @Drnasap @ElieAzoulay5 @jigidivatia @AlhazzaniW @NaomiHammond @criticcaredoc […]
The post Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method. appeared first on Links Medicus.
Boosting immunity to COVID-19 vaccines – “New studies highlight the immunological benefits of COVID-19 vaccine boosters, but questions remain over how to best make use of a limited global supply”.
vendredi, 12 novembre 2021 11:51 Écrit par Zouhair SouissiBoosting immunity to COVID-19 vaccines – Nature Medicine
The post Boosting immunity to COVID-19 vaccines – “New studies highlight the immunological benefits of COVID-19 vaccine boosters, but questions remain over how to best make use of a limited global supply”. appeared first on Links Medicus.
RCT: BBV152 (India’s COVAXIN) has an overall vaccine efficacy of 77.8% against symptomatic Covid-19 in adults.
vendredi, 12 novembre 2021 11:51 Écrit par Zouhair SouissiEfficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial – The Lancet Invited Commentary: Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19 – The Lancet Related: WHO issues emergency use approval for India’s Covaxin. Commentary on Twitter NEW—Interim data from a phase […]
The post RCT: BBV152 (India’s COVAXIN) has an overall vaccine efficacy of 77.8% against symptomatic Covid-19 in adults. appeared first on Links Medicus.
Perspective | COVID’s endgame: Scientists have a clue about where SARS-CoV-2 is headed.
jeudi, 11 novembre 2021 10:24 Écrit par Zouhair SouissiCOVID’s endgame: Scientists have a clue about where SARS-CoV-2 is headed – NPR
The post Perspective | COVID’s endgame: Scientists have a clue about where SARS-CoV-2 is headed. appeared first on Links Medicus.
M-A: Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19.
jeudi, 11 novembre 2021 10:24 Écrit par Zouhair SouissiLow vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: a meta-analysis and GRADE assessment of cohort studies and RCTs – Nutritional Journal
The post M-A: Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19. appeared first on Links Medicus.
COVID antiviral pills: what scientists still want to know – “Drugs like Molnupiravir and Paxlovid could change the course of the pandemic if clinical trial results hold up in the real world”.
jeudi, 11 novembre 2021 10:24 Écrit par Zouhair SouissiCOVID antiviral pills: what scientists still want to know – Nature Related: [Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study. A prominent virologist warns new COVID-19 pill could unleash dangerous mutants. Others see […]
The post COVID antiviral pills: what scientists still want to know – “Drugs like Molnupiravir and Paxlovid could change the course of the pandemic if clinical trial results hold up in the real world”. appeared first on Links Medicus.
